SMTL ID : 3kc3.2 (4 other biounits)

MK2 complexed to inhibitor N4-(7-(benzofuran-2-yl)-1H-indazol-5-yl)pyrimidine-2,4-diamine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.90 Å

Oligo State

homo-trimer

Ligands

3 x MK2: N~4~-[7-(1-benzofuran-2-yl)-1H-indazol-5-yl]pyrimidine-2,4-diamine(Non-covalent)

MK2.1: 13 residues within 4Å: Chain A: L.30, V.38, A.51, K.53, M.98, E.99, C.100, L.101, D.102, G.104, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.30, A:V.38, A:L.153 Hydrogen bonds: A:L.101, A:L.101, A:T.166, A:T.166, A:D.167 Salt bridges: A:D.167 MK2.2: 16 residues within 4Å: Chain B: L.30, L.32, V.38, A.51, K.53, H.68, M.98, E.99, C.100, L.101, D.102, G.104, E.105, L.153, T.166, D.167 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:L.30, B:V.38, B:L.153 Hydrogen bonds: B:L.101, B:L.101, B:T.166, B:T.166, B:D.167 Salt bridges: B:D.167 MK2.3: 14 residues within 4Å: Chain C: L.30, G.33, V.38, A.51, K.53, H.68, M.98, E.99, L.101, D.102, G.104, L.153, T.166, D.167 7 PLIP interactions: 7 interactions with chain C Hydrophobic interactions: C:V.38, C:L.153 Hydrogen bonds: C:L.101, C:L.101, C:T.166, C:D.167 Salt bridges: C:D.167

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Argiriadi, M.A. et al., 2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding mode. Bioorg.Med.Chem.Lett. (2010)

Release Date

2010-01-12

Peptides

MAP kinase-activated protein kinase 2: ABC

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
E

C
J

MAP kinase-activated protein kinase 2

Related Entries With Identical Sequence